Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

TherapeuticsMD Inc

TXMD
Current price
0.73 USD -0.0048 USD (-0.66%)
Last closed 0.74 USD
ISIN US88338N1072
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 13 608 231 USD
Yield for 12 month -68.47 %
1Y
3Y
5Y
10Y
15Y
TXMD
21.11.2021 - 28.11.2021

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. Address: 951 Yamato Road, Boca Raton, FL, United States, 33431

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.00 USD

P/E ratio

Dividend Yield

Current Year

+1 302 000 USD

Last Year

+69 963 000 USD

Current Quarter

+547 000 USD

Last Quarter

+234 000 USD

Current Year

+1 302 000 USD

Last Year

+68 566 000 USD

Current Quarter

+547 000 USD

Last Quarter

+234 000 USD

Key Figures TXMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -4 545 000 USD
Operating Margin TTM -157.04 %
Price to Earnings
Return On Assets TTM -6.65 %
PEG Ratio -0.73
Return On Equity TTM -14.39 %
Wall Street Target Price 5.00 USD
Revenue TTM 1 596 000 USD
Book Value 2.35 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -46.50 %
Dividend Yield
Gross Profit TTM 68 113 000 USD
Earnings per share -0.35 USD
Diluted Eps TTM -0.35 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -207.77 %

Dividend Analytics TXMD

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History TXMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:50
Payout Ratio
Last Split Date 09.05.2022

Stock Valuation TXMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 2.29
Enterprise Value Revenue 10.00
Price Sales TTM 8.53
Enterprise Value EBITDA 14.81
Price Book MRQ 0.50

Financials TXMD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TXMD

For 52 weeks

1.10 USD 2.75 USD
50 Day MA 1.47 USD
Shares Short Prior Month 30 126
200 Day MA 1.82 USD
Short Ratio 0.95
Shares Short 21 081
Short Percent 0.25 %